Table 1.
Summarization of the clinical parameters in subtypes.
| Parameters | MoS1 | MoS2 | MoS3 | p Value |
|---|---|---|---|---|
| Numbers | 58 | 86 | 81 | |
| Death events (%) | 32 (55.2) | 11 (12.8) | 24 (29.6) | <0.001* |
| Age | 61.64 ± 11.93 | 60.99 ± 11.14 | 60.49 ± 11.44 | 0.852 |
| Grade (%) | ||||
| G1 | 0 (0.0) | 4 (4.7) | 0 (0.0) | <0.001* |
| G2 | 12 (20.7) | 39 (45.3) | 39 (48.1) | |
| G3 | 21 (36.2) | 37 (43.0) | 33 (40.7) | |
| G4 | 24 (41.4) | 4 (4.7) | 9 (11.1) | |
| Unknown | 1 (1.7) | 2 (2.3) | 0 (0.0) | |
| Stage (%) | ||||
| Stage I | 15 (25.9) | 55 (64.0) | 42 (51.9) | <0.001* |
| Stage II | 6 (10.3) | 11 (12.8) | 7 (8.6) | |
| Stage III | 20 (34.5) | 14 (16.3) | 16 (19.8) | |
| Stage IV | 17 (29.3) | 6 (7.0) | 14 (17.3) | |
| Unknown | 0 (0.0) | 0 (0.0) | 2 (2.5) | |
| New tumor (%) | ||||
| Tumor free | 27 (46.6) | 70 (81.4) | 53 (65.4) | <0.001* |
| With tumor | 27 (46.6) | 11 (12.8) | 25 (30.9) | |
| Unknown | 4 (6.9) | 5 (5.8) | 3 (3.7) |
*
p < 0.05.